Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
No Data
Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025
Jyong Biotech | 20-F: Registration statement / Annual report / Transition report
Jyong Biotech Delays Annual 20-F (Yearly Report)
Jyong Biotech Updates Market Access Strategy for Innovative Botanical Drugs, Establishing Multiple Competitive Advantages for New Drug Portfolio
Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative Drug MCS-2
12 Health Care Stocks Moving In Wednesday's After-Market Session